Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil
Press Releases
March 31, 2025

Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil

Kazia to receive USD $1 million from Vivesto for the intellectual property and trademark assets rights to the oncology drug candidate, Cantrixil

bradford

The Bradford Era

Local & Social